adesso 관리

Mr. Mark Lohweber serves as Head of Line-of-Business Banking at adesso SE and serves as its Member of Executive Board since July 01, 2023. He is familiar with the challenges facing growth-oriented companie...

리더십 팀

이름	위치	테뉴어	보상	소유권
Volker Gruhn	Co-Founder & Chairperson of the Supervisory Board	27.8yrs	€58.00k	26.59% € 152.1m
Mark Lohweber	Chairman of Executive Board & CEO	1.3yrs	€318.00k	데이터 없음
Rainer Rudolf	Co-Founder & Member of the Supervisory Board	27.8yrs	€30.00k	16.15% € 92.4m
Jorg Schroeder	CFO & Member of Executive board	5.2yrs	€322.00k	데이터 없음
Andreas Prenneis	MD & Member of Executive Board	9.6yrs	€338.00k	데이터 없음
Kristina Gerwert	Member of Executive Board	1.3yrs	€242.00k	데이터 없음
Benedikt Bonnmann	Member of the Executive Board	less than a year	데이터 없음	데이터 없음
Martin Mollmann	Head of Investor Relations	no data	데이터 없음	데이터 없음
Sven Kruger	Chief Marketing Officer	3.3yrs	데이터 없음	데이터 없음
Jürgen Angele	Head of the Artificial Intelligence Competence Centre	no data	데이터 없음	데이터 없음

4.3yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: ADN1 의 관리팀은 경험 ( 4.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Volker Gruhn	Co-Founder & Chairperson of the Supervisory Board	27.8yrs	€58.00k	26.59% € 152.1m
Rainer Rudolf	Co-Founder & Member of the Supervisory Board	11.3yrs	€30.00k	16.15% € 92.4m
Friedrich Wobking	Vice Chairman of the Supervisory Board	14.4yrs	€35.00k	데이터 없음
Hermann Kogler	Member of the Supervisory Board	9.4yrs	€33.00k	데이터 없음
Stefanie Kemp	Member of the Supervisory Board	1.8yrs	€25.00k	데이터 없음
Michael Zorc	Member of Supervisory Board	1.4yrs	€15.00k	데이터 없음

10.4yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: ADN1 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 10.4 년).

adesso 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

adesso SE Announces CEO Changes

adesso SE Announces Board Changes

Recent updates

adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target

Third quarter 2024 earnings released: EPS: €1.67 (vs €0.85 in 3Q 2023)

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

Now 24% overvalued

It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks

Second quarter 2024 earnings released: €1.02 loss per share (vs €1.18 loss in 2Q 2023)

Price target decreased by 7.4% to €162

Upcoming dividend of €0.70 per share

New major risk - Financial position

adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year

New major risk - Financial position

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70

Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)

Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

Consensus EPS estimates fall by 13%

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Full year 2023 earnings: EPS misses analyst expectations

Is adesso SE (ETR:ADN1) Trading At A 44% Discount?

adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward

Consensus EPS estimates fall by 63%, revenue upgraded

Dividend increased to €0.70

A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)

Consensus EPS estimates fall by 61%

adesso SE to Report Fiscal Year 2023 Results on Mar 25, 2024

adesso SE to Report Q3, 2024 Results on Nov 14, 2024

Third quarter 2023 earnings released: EPS: €0.85 (vs €2.01 in 3Q 2022)

New minor risk - Earnings quality

Consensus EPS estimates fall by 19%

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

adesso SE Announces CEO Changes

Consensus EPS estimates fall by 14%, revenue upgraded

Second quarter 2023 earnings released: €1.18 loss per share (vs €0.29 loss in 2Q 2022)

Now 22% undervalued after recent price drop

At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

Now 20% undervalued after recent price drop

adesso SE Announces Board Changes

Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)

Now 21% undervalued after recent price drop

Upcoming dividend of €0.65 per share at 0.5% yield

First quarter 2023 earnings released: EPS: €0.28 (vs €1.92 in 1Q 2022)

Consensus EPS estimates fall by 10%, revenue upgraded

adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business

Now 24% undervalued after recent price drop

What Does adesso SE's (ETR:ADN1) Share Price Indicate?

Now 21% undervalued after recent price drop

adesso SE (XTRA:ADN1) signed an agreement to acquire 51% stake in Wepex GmbH.

adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Returns On Capital At adesso (ETR:ADN1) Have Stalled

adesso SE (XTRA:ADN1) acquired WebScience Srl.

Calculating The Fair Value Of adesso SE (ETR:ADN1)

At €138, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

adesso SE to Report Q1, 2023 Results on May 15, 2023

Third quarter 2022 earnings released: EPS: €2.01 (vs €1.86 in 3Q 2021)

We Think adesso (ETR:ADN1) Can Stay On Top Of Its Debt

Price target decreased to €208

Second quarter 2022 earnings released: €0.29 loss per share (vs €1.12 profit in 2Q 2021)

adesso SE Revises Earnings Guidance for the Full Year 2022

Why adesso SE (ETR:ADN1) Could Be Worth Watching

adesso SE Revises Earnings Guidance for the Full Year 2022

adesso SE (XTRA:ADN1) acquired Quadox Ag.

adesso (ETR:ADN1) Hasn't Managed To Accelerate Its Returns

adesso SE (XTRA:ADN1) acquired remaining 41% stake in com2m GmbH.

Investor sentiment deteriorated over the past week

Now 22% undervalued after recent price drop

Upcoming dividend of €0.60 per share

First quarter 2022 earnings: EPS exceeds analyst expectations

Is adesso (ETR:ADN1) A Risky Investment?

Now 22% undervalued after recent price drop

Is It Too Late To Consider Buying adesso SE (ETR:ADN1)?

adesso (ETR:ADN1) Might Be Having Difficulty Using Its Capital Effectively

adesso SE (XTRA:ADN1) acquired Purple Scout AB from Johan Strömhage and Helena Bendz and others.

Now 23% undervalued after recent price drop